Figure 4
Figure 4. Morgana is underexpressed in a subgroup of CML Ph+ patients. (A) Morgana IHC staining on BM biopsies of representative Morgana normal (cases 7 and 8) and Morgana low (cases 9 and 10) Ph+ CML patients. The scale bar = 100 μm. (B) The graph indicates the percentage of Ph+ CML patients expressing morgana at normal (84%) and low (16%) levels as assessed by IHC analysis on BM sections (n = 19). (C) Percentages of CD34+ BM cells with >2 centrosomes in CML patients at diagnosis, expressing normal or low morgana levels (n = 4 patients per group) and healthy donors (n = 3). The black bar indicates low morgana expression levels. (D) Percentage of aneuploid metaphases in Morgana normal and Morgana low Ph+ CML and Morgana low aCML BM cells compared with normal BM cells. The black bars indicate low morgana expression levels. *P < .05.

Morgana is underexpressed in a subgroup of CML Ph+ patients. (A) Morgana IHC staining on BM biopsies of representative Morgana normal (cases 7 and 8) and Morgana low (cases 9 and 10) Ph+ CML patients. The scale bar = 100 μm. (B) The graph indicates the percentage of Ph+ CML patients expressing morgana at normal (84%) and low (16%) levels as assessed by IHC analysis on BM sections (n = 19). (C) Percentages of CD34+ BM cells with >2 centrosomes in CML patients at diagnosis, expressing normal or low morgana levels (n = 4 patients per group) and healthy donors (n = 3). The black bar indicates low morgana expression levels. (D) Percentage of aneuploid metaphases in Morgana normal and Morgana low Ph+ CML and Morgana low aCML BM cells compared with normal BM cells. The black bars indicate low morgana expression levels. *P < .05.

Close Modal

or Create an Account

Close Modal
Close Modal